RESLIZUMAB

RESLIZUMAB was reported 688 times

RESLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE COMPLICATION 1 0.0476
1 BRONCHOPLASTY 1 0.0417
2 NON-SMALL CELL LUNG CANCER STAGE IIIA 1 0.0357
3 CATECHOLAMINE CRISIS 1 0.0270
4 EXERCISE TOLERANCE INCREASED 1 0.0233
5 EOSINOPENIA 3 0.0227
6 ATYPICAL MIGRAINE 1 0.0217
7 RECTAL PROLAPSE REPAIR 1 0.0189
8 ADRENAL SUPPRESSION 12 0.0142
9 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 2 0.0135
10 RETROPERITONEAL CANCER 1 0.0125
11 RETROPERITONEAL NEOPLASM 1 0.0119
12 INFUSION SITE HYPOAESTHESIA 1 0.0105
13 ENCAPSULATION REACTION 1 0.0097
14 LARYNGEAL DYSKINESIA 1 0.0078
15 PAPILLARY RENAL CELL CARCINOMA 1 0.0074
16 INCISION SITE OEDEMA 1 0.0072
17 CRUSH SYNDROME 1 0.0071
18 GASTRIC VOLVULUS 1 0.0069
19 OESOPHAGOGASTRIC FUNDOPLASTY 1 0.0059
20 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 1 0.0056
21 PICKWICKIAN SYNDROME 1 0.0053
22 NSAID EXACERBATED RESPIRATORY DISEASE 2 0.0053
23 STENT REMOVAL 1 0.0051
24 EOSINOPHILIC BRONCHITIS 1 0.0050
25 PLACENTA ACCRETA 1 0.0046
26 CHRONIC SPONTANEOUS URTICARIA 5 0.0043
27 VOCAL CORD PARESIS 1 0.0043
28 FUNGAL PHARYNGITIS 1 0.0040
29 DRAIN PLACEMENT 1 0.0039
30 PULMONARY GRANULOMA 4 0.0035
31 EAR INFLAMMATION 1 0.0035
32 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 7 0.0034
33 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2 0.0033
34 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 1 0.0033
35 ABDOMINOPLASTY 1 0.0030
36 PARADOXICAL DRUG REACTION 10 0.0027
37 CREATINE KINASE INCREASED 2 0.0026
38 WRONG DRUG 1 0.0026
39 HEPATITIS VIRAL 2 0.0025
40 NOCTURNAL DYSPNOEA 3 0.0024
41 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
42 FOLLICULAR LYMPHOMA 2 0.0023
43 PEAK EXPIRATORY FLOW RATE DECREASED 1 0.0023
44 MYCOBACTERIUM AVIUM COMPLEX INFECTION 6 0.0022
45 INFUSION SITE HAEMATOMA 1 0.0021
46 BLASTOMYCOSIS 1 0.0021
47 DRAINAGE 1 0.0020
48 SPUTUM RETENTION 2 0.0020
49 BLOOD GASES ABNORMAL 1 0.0019
50 HYPEREOSINOPHILIC SYNDROME 1 0.0018
51 EPIGLOTTITIS 1 0.0018
52 INTRACRANIAL HAEMATOMA 1 0.0018
53 SINUS POLYP 1 0.0017
54 MENTAL DISABILITY 1 0.0017
55 ENDOSCOPY 1 0.0017
56 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 1 0.0016
57 DIAPHRAGMATIC HERNIA 1 0.0016
58 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
59 MITRAL VALVE CALCIFICATION 1 0.0016
60 PNEUMONIA NECROTISING 1 0.0015
61 RENAL SURGERY 1 0.0015
62 BRONCHITIS VIRAL 1 0.0015
63 HYPOPLASTIC LEFT HEART SYNDROME 1 0.0015
64 CLEAR CELL RENAL CELL CARCINOMA 1 0.0014
65 SOFT TISSUE INJURY 1 0.0013
66 BASOPHIL COUNT INCREASED 1 0.0013
67 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
68 GENITAL HERPES 2 0.0013
69 INFUSION SITE EXTRAVASATION 8 0.0013
70 EXPOSURE VIA BODY FLUID 1 0.0013
71 GOUTY ARTHRITIS 1 0.0013
72 PROCEDURAL NAUSEA 1 0.0012
73 PSEUDOMONAS TEST POSITIVE 1 0.0012
74 VEIN RUPTURE 2 0.0012
75 MEAN PLATELET VOLUME DECREASED 1 0.0012
76 LUNG HYPERINFLATION 1 0.0012
77 POUCHITIS 1 0.0012
78 STEROID DEPENDENCE 1 0.0011
79 HYPERPLASIA 1 0.0011
80 OROPHARYNGEAL CANDIDIASIS 1 0.0011
81 NORMAL NEWBORN 6 0.0011
82 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
83 PHARYNGEAL HYPOAESTHESIA 1 0.0011
84 BLOOD UREA ABNORMAL 1 0.0011
85 MECHANICAL VENTILATION 2 0.0011
86 COARCTATION OF THE AORTA 1 0.0010
87 BRAIN HYPOXIA 1 0.0010
88 INFUSION SITE MASS 1 0.0009
89 ACARODERMATITIS 1 0.0009
90 SOFT TISSUE DISORDER 1 0.0009
91 BENIGN NEOPLASM 1 0.0009
92 SINUS PAIN 2 0.0009
93 ASTHMA 95 0.0008
94 EOSINOPHIL COUNT DECREASED 2 0.0008
95 BRONCHIAL HYPERREACTIVITY 1 0.0008
96 LIP INJURY 1 0.0008
97 VULVOVAGINAL CANDIDIASIS 1 0.0007
98 BILIARY TRACT DISORDER 1 0.0007
99 VIRAEMIA 1 0.0007
100 MAST CELL ACTIVATION SYNDROME 1 0.0007
101 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
102 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
103 INFUSION SITE INDURATION 1 0.0007
104 WHEEZING 40 0.0007
105 EPICONDYLITIS 1 0.0007
106 EMERGENCY CARE 2 0.0007
107 SECRETION DISCHARGE 8 0.0006
108 FRUSTRATION TOLERANCE DECREASED 5 0.0006
109 NASAL POLYPS 3 0.0006
110 OXYGEN THERAPY 1 0.0006
111 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
112 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
113 BRONCHIECTASIS 4 0.0006
114 PAPILLARY THYROID CANCER 1 0.0006
115 VASCULAR PSEUDOANEURYSM 1 0.0006
116 INFUSION SITE DISCHARGE 1 0.0006
117 PRODUCT SUPPLY ISSUE 4 0.0006
118 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
119 OESOPHAGEAL SPASM 1 0.0005
120 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
121 RHEUMATIC DISORDER 1 0.0005
122 ARTERIAL THROMBOSIS 1 0.0005
123 CHOLANGITIS SCLEROSING 1 0.0005
124 DIVERTICULAR PERFORATION 1 0.0005
125 POLYCYTHAEMIA 1 0.0005
126 THROAT TIGHTNESS 13 0.0005
127 SLEEP DEFICIT 1 0.0005
128 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
129 SPUTUM INCREASED 1 0.0005
130 ASPERGILLUS INFECTION 3 0.0005
131 LIMB MASS 1 0.0005
132 LUNG INFILTRATION 4 0.0005
133 SINUS CONGESTION 6 0.0004
134 REBOUND EFFECT 5 0.0004
135 BREAKTHROUGH PAIN 1 0.0004
136 VOLVULUS 1 0.0004
137 DIABETES INSIPIDUS 1 0.0004
138 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
139 BODY TEMPERATURE DECREASED 4 0.0004
140 DEVICE INFUSION ISSUE 1 0.0004
141 VEIN DISORDER 2 0.0004
142 EOSINOPHILIA 7 0.0004
143 PEMPHIGOID 3 0.0004
144 INCREASED BRONCHIAL SECRETION 1 0.0004
145 ATRIOVENTRICULAR BLOCK 3 0.0004
146 INCORRECT DOSE ADMINISTERED 88 0.0004
147 RETINAL DISORDER 1 0.0004
148 RADICULOPATHY 1 0.0004
149 CLUMSINESS 1 0.0004
150 IMMUNE-MEDIATED MYOSITIS 1 0.0004
151 ANAL HAEMORRHAGE 1 0.0004
152 OXYGEN SATURATION DECREASED 20 0.0004
153 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
154 RESPIRATORY SYMPTOM 1 0.0004
155 HEART VALVE INCOMPETENCE 1 0.0003
156 PARAESTHESIA ORAL 5 0.0003
157 EYELID MARGIN CRUSTING 1 0.0003
158 HYPERTENSION 73 0.0003
159 CAESAREAN SECTION 4 0.0003
160 ENERGY INCREASED 2 0.0003
161 CATARACT OPERATION 2 0.0003
162 OROPHARYNGEAL PAIN 31 0.0003
163 THYROIDITIS 1 0.0003
164 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
165 CENTRAL VENOUS CATHETERISATION 1 0.0003
166 CRANIOCEREBRAL INJURY 1 0.0003
167 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
168 EYELIDS PRURITUS 1 0.0003
169 INJECTION SITE HYPERSENSITIVITY 1 0.0003
170 INFUSION SITE SWELLING 2 0.0003
171 INFUSION SITE PRURITUS 1 0.0003
172 SPINAL DISORDER 3 0.0003
173 POLYMYALGIA RHEUMATICA 1 0.0003
174 ORTHOPNOEA 1 0.0003
175 ADVERSE REACTION 4 0.0003
176 ULCER HAEMORRHAGE 2 0.0003
177 APPLICATION SITE DRYNESS 1 0.0003
178 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
179 ABNORMAL LOSS OF WEIGHT 2 0.0003
180 INJECTION SITE WARMTH 6 0.0003
181 HEPATIC FIBROSIS 1 0.0003
182 RESPIRATION ABNORMAL 2 0.0003
183 BLOOD CREATININE ABNORMAL 1 0.0003
184 FORMICATION 2 0.0003
185 AORTIC STENOSIS 1 0.0003
186 LOGORRHOEA 1 0.0003
187 TONGUE DISORDER 2 0.0003
188 SPONDYLITIS 1 0.0003
189 CUTANEOUS VASCULITIS 1 0.0003
190 PULMONARY MASS 4 0.0003
191 SNEEZING 6 0.0003
192 THROAT CLEARING 1 0.0003
193 DYSPNOEA EXERTIONAL 10 0.0003
194 CHEST DISCOMFORT 27 0.0003
195 THYROID MASS 1 0.0003
196 GLAUCOMA 5 0.0003
197 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
198 FAECES HARD 1 0.0003
199 RHINOVIRUS INFECTION 1 0.0003
200 MUSCLE RUPTURE 1 0.0003
201 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
202 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
203 OESOPHAGEAL PAIN 1 0.0003
204 OESOPHAGEAL CANDIDIASIS 1 0.0003
205 ATRIAL FLUTTER 2 0.0003
206 OBSTRUCTION 1 0.0003
207 TRIGEMINAL NEURALGIA 1 0.0002
208 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
209 GOITRE 1 0.0002
210 GASTROINTESTINAL PERFORATION 1 0.0002
211 LIVE BIRTH 2 0.0002
212 AORTIC VALVE INCOMPETENCE 1 0.0002
213 FACIAL PARALYSIS 2 0.0002
214 PRODUCT DISPENSING ISSUE 1 0.0002
215 PRODUCTIVE COUGH 11 0.0002
216 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
217 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
218 DYSPHEMIA 1 0.0002
219 SARS-COV-2 TEST POSITIVE 3 0.0002
220 LIGAMENT RUPTURE 1 0.0002
221 ABDOMINAL ABSCESS 1 0.0002
222 CATHETERISATION CARDIAC 1 0.0002
223 SWOLLEN TONGUE 7 0.0002
224 FACIAL PAIN 2 0.0002
225 DYSPHONIA 13 0.0002
226 SUSPECTED OFF LABEL USE 1 0.0002
227 SYNOVIAL CYST 1 0.0002
228 SPUTUM DISCOLOURED 2 0.0002
229 BRONCHOSPASM 3 0.0002
230 LIMB OPERATION 1 0.0002
231 VITAMIN D DEFICIENCY 2 0.0002
232 PHARYNGEAL SWELLING 2 0.0002
233 ORGANISING PNEUMONIA 1 0.0002
234 HEPATIC ENZYME ABNORMAL 1 0.0002
235 HEART RATE DECREASED 7 0.0002
236 OSTEOPENIA 3 0.0002
237 EYELID PTOSIS 2 0.0002
238 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
239 EAR DISCOMFORT 2 0.0002
240 POOR VENOUS ACCESS 2 0.0002
241 WEIGHT FLUCTUATION 2 0.0002
242 FULL BLOOD COUNT ABNORMAL 2 0.0002
243 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
244 HEART RATE INCREASED 18 0.0002
245 CHOKING SENSATION 1 0.0002
246 PROSTATIC DISORDER 1 0.0002
247 ANAPHYLACTIC REACTION 10 0.0002
248 CYSTIC FIBROSIS 1 0.0002
249 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
250 THROAT IRRITATION 8 0.0002
251 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
252 MYALGIA 30 0.0002
253 NEUROLOGICAL SYMPTOM 1 0.0002
254 EXERCISE TOLERANCE DECREASED 1 0.0002
255 SKIN ATROPHY 1 0.0002
256 HERPES VIRUS INFECTION 1 0.0002
257 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
258 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
259 NASAL CONGESTION 10 0.0002
260 DYSPNOEA 96 0.0002
261 COVID-19 PNEUMONIA 2 0.0002
262 COUGH 47 0.0002
263 SYMPTOM RECURRENCE 1 0.0002
264 LUNG DISORDER 8 0.0002
265 PRE-EXISTING CONDITION IMPROVED 1 0.0002
266 SWELLING OF EYELID 1 0.0002
267 ABDOMINAL PAIN LOWER 4 0.0002
268 INFUSION SITE PAIN 2 0.0002
269 CARDIAC FLUTTER 1 0.0002
270 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
271 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
272 SOMNAMBULISM 1 0.0002
273 PULMONARY CONGESTION 2 0.0002
274 CORONAVIRUS INFECTION 1 0.0002
275 CARDIAC FAILURE ACUTE 1 0.0001
276 URTICARIA 25 0.0001
277 QUALITY OF LIFE DECREASED 2 0.0001
278 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
279 MASS 2 0.0001
280 SKIN REACTION 2 0.0001
281 FAECES DISCOLOURED 3 0.0001
282 FAECES SOFT 1 0.0001
283 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
284 RESPIRATORY DISORDER 4 0.0001
285 HYPOAESTHESIA ORAL 2 0.0001
286 INSURANCE ISSUE 2 0.0001
287 LIPASE INCREASED 1 0.0001
288 PHARYNGEAL OEDEMA 2 0.0001
289 CONCUSSION 1 0.0001
290 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
291 MULTIPLE ALLERGIES 1 0.0001
292 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
293 PNEUMOTHORAX 2 0.0001
294 TRICUSPID VALVE INCOMPETENCE 1 0.0001
295 ABNORMAL FAECES 1 0.0001
296 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
297 VIRAL INFECTION 4 0.0001
298 EOSINOPHIL COUNT INCREASED 1 0.0001
299 EYE PRURITUS 4 0.0001
300 ANAPHYLACTIC SHOCK 3 0.0001
301 MUSCLE STRAIN 1 0.0001
302 LOCAL SWELLING 2 0.0001
303 COLD SWEAT 2 0.0001
304 IMMUNOSUPPRESSION 1 0.0001
305 PRODUCT COMMUNICATION ISSUE 1 0.0001
306 GASTROINTESTINAL INFECTION 1 0.0001
307 MYOSITIS 1 0.0001
308 ANAL INCONTINENCE 1 0.0001
309 GASTROENTERITIS VIRAL 2 0.0001
310 NEPHROLITHIASIS 5 0.0001
311 PNEUMONIA BACTERIAL 1 0.0001
312 BRAIN NEOPLASM 1 0.0001
313 RESPIRATORY DISTRESS 3 0.0001
314 ADVERSE EVENT 10 0.0001
315 FEELING COLD 3 0.0001
316 MIDDLE INSOMNIA 2 0.0001
317 DIARRHOEA HAEMORRHAGIC 1 0.0001
318 LACERATION 1 0.0001
319 LEUKAEMIA 1 0.0001
320 INTENTIONAL DOSE OMISSION 3 0.0001
321 EYE INFLAMMATION 1 0.0001
322 SLEEP APNOEA SYNDROME 2 0.0001
323 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
324 HERNIA 2 0.0001
325 AUTOIMMUNE DISORDER 1 0.0001
326 PNEUMONIA 33 0.0001
327 KIDNEY INFECTION 2 0.0001
328 BLADDER DISORDER 1 0.0001
329 INABILITY TO AFFORD MEDICATION 1 0.0001
330 POOR QUALITY DEVICE USED 1 0.0001
331 TOXIC SKIN ERUPTION 1 0.0001
332 TOOTH ABSCESS 1 0.0001
333 HELICOBACTER INFECTION 1 0.0001
334 RIB FRACTURE 2 0.0001
335 LIMB DISCOMFORT 3 0.0001
336 BODY HEIGHT DECREASED 1 0.0001
337 PRURITUS GENERALISED 2 0.0001
338 SKIN LACERATION 1 0.0001
339 MENTAL DISORDER 4 0.0001
340 PULMONARY THROMBOSIS 1 0.0001
341 OSTEONECROSIS 3 0.0001
342 FOOT DEFORMITY 1 0.0001
343 INFLUENZA 10 0.0001
344 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
345 MITRAL VALVE INCOMPETENCE 1 0.0001
346 IMPAIRED DRIVING ABILITY 1 0.0001
347 SCAB 1 0.0001
348 CHOLECYSTECTOMY 1 0.0001
349 INTERNAL HAEMORRHAGE 1 0.0001
350 ILLNESS 9 0.0001
351 HERPES ZOSTER 5 0.0001
352 WEIGHT DECREASED 24 0.0001
353 BLOOD PRESSURE INCREASED 13 0.0001
354 ATAXIA 1 0.0001
355 DRUG EFFECT INCOMPLETE 3 0.0001
356 ADRENAL INSUFFICIENCY 1 0.0001
357 SCHIZOPHRENIA 1 0.0001
358 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
359 TENDON RUPTURE 1 0.0001
360 HYPERSENSITIVITY 15 0.0001
361 EYE SWELLING 3 0.0001
362 PHARYNGITIS 1 0.0001
363 PNEUMONIA ASPIRATION 2 0.0001
364 INJECTION SITE DISCOLOURATION 1 0.0001
365 MUSCLE ATROPHY 1 0.0001
366 INFLAMMATION 4 0.0001
367 RASH GENERALISED 2 0.0001
368 DIPLOPIA 2 0.0001
369 SWELLING FACE 5 0.0001
370 RESPIRATORY TRACT INFECTION 2 0.0001
371 PLATELET COUNT INCREASED 1 0.0001
372 IMMUNE SYSTEM DISORDER 1 0.0001
373 BLINDNESS 3 0.0001
374 OSTEOPOROSIS 3 0.0001
375 PERIPHERAL COLDNESS 1 0.0001
376 RESPIRATORY ARREST 2 0.0001
377 ORAL DISCOMFORT 1 0.0001
378 APHONIA 1 0.0001
379 PERIPHERAL SWELLING 11 0.0001
380 SEASONAL ALLERGY 1 0.0001
381 CHEST PAIN 13 0.0001
382 HYPERTHYROIDISM 1 0.0001
383 FLUSHING 7 0.0001
384 FLUID OVERLOAD 1 0.0001
385 HEADACHE 43 0.0001
386 GASTROENTERITIS 1 0.0001
387 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
388 CHILLS 8 0.0001
389 IMMUNODEFICIENCY 1 0.0001
390 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
391 FEELING ABNORMAL 16 0.0001
392 LACRIMATION INCREASED 2 0.0001
393 ALOPECIA 13 0.0001
394 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
395 HIP ARTHROPLASTY 1 0.0001
396 DEVICE RELATED INFECTION 1 0.0001
397 MUSCULOSKELETAL CHEST PAIN 1 0.0001
398 LUNG INFECTION 1 0.0001
399 SWELLING 6 0.0001
400 ERYTHEMA 13 0.0001
401 COMA 3 0.0001
402 DRUG INEFFECTIVE 83 0.0001
403 RESPIRATORY TRACT CONGESTION 1 0.0001
404 HIP FRACTURE 2 0.0001
405 MUSCLE TIGHTNESS 1 0.0001
406 PAIN IN EXTREMITY 18 0.0001
407 INFLUENZA LIKE ILLNESS 5 0.0001
408 DRY EYE 3 0.0001
409 LIP SWELLING 2 0.0001
410 COAGULOPATHY 1 0.0001
411 GAIT INABILITY 2 0.0001
412 TYPE 2 DIABETES MELLITUS 2 0.0001
413 MALAISE 26 0.0001
414 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
415 ANGER 2 0.0001
416 HEMIPARESIS 1 0.0001
417 FLUID RETENTION 3 0.0001
418 SCAR 1 0.0001
419 MUSCULOSKELETAL DISCOMFORT 1 0.0001
420 PRURITUS 22 0.0001
421 GALLBLADDER DISORDER 1 0.0001
422 OSTEOMYELITIS 1 0.0001
423 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
424 BLOOD GLUCOSE ABNORMAL 1 0.0001
425 BACTERIAL INFECTION 1 0.0001
426 WEIGHT INCREASED 12 0.0001
427 PHOTOPHOBIA 1 0.0001
428 MUSCULAR WEAKNESS 6 0.0001
429 FOOT FRACTURE 1 0.0001
430 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
431 SEROTONIN SYNDROME 1 0.0001
432 LOWER LIMB FRACTURE 1 0.0001
433 ACUTE RESPIRATORY FAILURE 1 0.0001
434 CONTUSION 5 0.0001
435 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
436 EAR PAIN 1 0.0001
437 PALPITATIONS 6 0.0001
438 ORAL HERPES 1 0.0001
439 BONE PAIN 3 0.0001
440 DISABILITY 1 0.0001
441 SINUS DISORDER 1 0.0001
442 HAEMATOCRIT DECREASED 1 0.0001
443 CATARACT 3 0.0001
444 FATIGUE 39 0.0001
445 ABORTION SPONTANEOUS 2 0.0000
446 DISCOMFORT 3 0.0000
447 INJURY ASSOCIATED WITH DEVICE 1 0.0000
448 FEELING HOT 3 0.0000
449 PRODUCT PREPARATION ERROR 1 0.0000
450 ABDOMINAL DISCOMFORT 8 0.0000
451 KNEE ARTHROPLASTY 1 0.0000
452 BACK PAIN 11 0.0000
453 OSTEOARTHRITIS 2 0.0000
454 IMPAIRED WORK ABILITY 1 0.0000
455 IRRITABLE BOWEL SYNDROME 1 0.0000
456 HYPOACUSIS 2 0.0000
457 BALANCE DISORDER 4 0.0000
458 SEPTIC SHOCK 2 0.0000
459 HOSPITALISATION 7 0.0000
460 PULMONARY OEDEMA 2 0.0000
461 ORAL PAIN 1 0.0000
462 GASTROINTESTINAL DISORDER 4 0.0000
463 RASH PAPULAR 1 0.0000
464 PANCREATITIS ACUTE 1 0.0000
465 PRODUCT DOSE OMISSION ISSUE 13 0.0000
466 SKIN DISCOLOURATION 2 0.0000
467 NASOPHARYNGITIS 8 0.0000
468 MUSCLE TWITCHING 1 0.0000
469 TREMOR 7 0.0000
470 PRODUCT PRESCRIBING ERROR 1 0.0000
471 MIGRAINE 4 0.0000
472 RASH ERYTHEMATOUS 2 0.0000
473 GAIT DISTURBANCE 8 0.0000
474 HEPATIC CANCER 1 0.0000
475 LOCALISED INFECTION 1 0.0000
476 FIBROMYALGIA 1 0.0000
477 NEURALGIA 1 0.0000
478 CEREBRAL INFARCTION 1 0.0000
479 BRONCHITIS 3 0.0000
480 COVID-19 7 0.0000
481 CELLULITIS 2 0.0000
482 DIABETES MELLITUS 3 0.0000
483 SINUSITIS 4 0.0000
484 THERAPY CESSATION 2 0.0000
485 HAEMATOMA 1 0.0000
486 EXPOSURE VIA SKIN CONTACT 1 0.0000
487 ARTHRALGIA 16 0.0000
488 VOMITING 18 0.0000
489 MUSCULOSKELETAL PAIN 2 0.0000
490 MUSCLE SPASMS 7 0.0000
491 ARTHRITIS 3 0.0000
492 JOINT STIFFNESS 1 0.0000
493 GASTRITIS 1 0.0000
494 BRADYCARDIA 2 0.0000
495 EAR INFECTION 1 0.0000
496 BREAST CANCER FEMALE 1 0.0000
497 THROMBOSIS 3 0.0000
498 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
499 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
500 RASH PRURITIC 2 0.0000
501 PALLOR 1 0.0000
502 PNEUMONITIS 1 0.0000
503 RASH 16 0.0000
504 NAUSEA 29 0.0000
505 DIVERTICULITIS 1 0.0000
506 ARTHROPATHY 2 0.0000
507 SEPSIS 4 0.0000
508 NECK PAIN 2 0.0000
509 BLISTER 2 0.0000
510 EYE PAIN 2 0.0000
511 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
512 PAIN IN JAW 1 0.0000
513 RED BLOOD CELL COUNT DECREASED 1 0.0000
514 PYREXIA 12 0.0000
515 INFECTION 5 0.0000
516 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
517 INSOMNIA 9 0.0000
518 IRRITABILITY 2 0.0000
519 CONDITION AGGRAVATED 10 0.0000
520 OEDEMA PERIPHERAL 4 0.0000
521 VERTIGO 2 0.0000
522 INJECTION SITE RASH 1 0.0000
523 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
524 PRODUCT USE ISSUE 6 0.0000
525 DYSPHAGIA 3 0.0000
526 HYPOTHYROIDISM 1 0.0000
527 LOSS OF CONSCIOUSNESS 4 0.0000
528 NIGHT SWEATS 1 0.0000
529 CHOLELITHIASIS 1 0.0000
530 EYE DISORDER 1 0.0000
531 NEOPLASM MALIGNANT 2 0.0000
532 HYPOTENSION 6 0.0000
533 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
534 URINARY TRACT INFECTION 5 0.0000
535 PAIN 18 0.0000
536 DELIRIUM 1 0.0000
537 HAEMORRHAGE 3 0.0000
538 MYOCARDIAL INFARCTION 5 0.0000
539 HYPOXIA 1 0.0000
540 SLEEP DISORDER 2 0.0000
541 LYMPHADENOPATHY 1 0.0000
542 DIZZINESS 14 0.0000
543 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
544 DYSURIA 1 0.0000
545 INJECTION SITE MASS 1 0.0000
546 FALL 9 0.0000
547 DYSARTHRIA 1 0.0000
548 COLITIS 1 0.0000
549 ACNE 2 0.0000
550 ACUTE KIDNEY INJURY 4 0.0000
551 INJECTION SITE SWELLING 2 0.0000
552 PARAESTHESIA 4 0.0000
553 ABNORMAL BEHAVIOUR 1 0.0000
554 DISORIENTATION 1 0.0000
555 INJECTION SITE BRUISING 2 0.0000
556 JOINT SWELLING 3 0.0000
557 CARDIAC ARREST 2 0.0000
558 RHABDOMYOLYSIS 1 0.0000
559 ASTHENIA 9 0.0000
560 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
561 CEREBROVASCULAR ACCIDENT 4 0.0000
562 RECTAL HAEMORRHAGE 1 0.0000
563 MUSCULOSKELETAL STIFFNESS 2 0.0000
564 INJECTION SITE PAIN 7 0.0000
565 DEHYDRATION 3 0.0000
566 DRY SKIN 3 0.0000
567 COLITIS ULCERATIVE 1 0.0000
568 ADVERSE DRUG REACTION 2 0.0000
569 THERAPY NON-RESPONDER 1 0.0000
570 VISION BLURRED 3 0.0000
571 DECREASED APPETITE 5 0.0000
572 ABDOMINAL PAIN 5 0.0000
573 COGNITIVE DISORDER 1 0.0000
574 OCULAR HYPERAEMIA 1 0.0000
575 ATRIAL FIBRILLATION 2 0.0000
576 DYSPEPSIA 2 0.0000
577 HAEMOGLOBIN DECREASED 2 0.0000
578 NERVOUSNESS 1 0.0000
579 DEPRESSED MOOD 1 0.0000
580 CONFUSIONAL STATE 3 0.0000
581 OEDEMA 1 0.0000
582 CONSTIPATION 4 0.0000
583 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
584 FLATULENCE 1 0.0000
585 ANXIETY 5 0.0000
586 LETHARGY 1 0.0000
587 SEIZURE 2 0.0000
588 SURGERY 1 0.0000
589 PLEURAL EFFUSION 1 0.0000
590 VISUAL IMPAIRMENT 2 0.0000
591 INJECTION SITE ERYTHEMA 2 0.0000
592 EXPOSURE DURING PREGNANCY 1 0.0000
593 HYPERHIDROSIS 2 0.0000
594 RHINORRHOEA 1 0.0000
595 DEEP VEIN THROMBOSIS 1 0.0000
596 AMNESIA 1 0.0000
597 INFUSION RELATED REACTION 1 0.0000
598 BLOOD PRESSURE DECREASED 1 0.0000
599 OFF LABEL USE 13 0.0000
600 MEMORY IMPAIRMENT 2 0.0000
601 INJECTION SITE REACTION 1 0.0000
602 BURNING SENSATION 1 0.0000
603 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
604 DIARRHOEA 9 0.0000
605 MOBILITY DECREASED 1 0.0000
606 RESPIRATORY FAILURE 1 0.0000
607 EPISTAXIS 1 0.0000
608 HALLUCINATION 1 0.0000
609 UNEVALUABLE EVENT 1 0.0000
610 INJECTION SITE HAEMORRHAGE 1 0.0000
611 CARDIAC FAILURE 1 0.0000
612 DRY MOUTH 1 0.0000
613 DRUG ABUSE 1 0.0000
614 TOXICITY TO VARIOUS AGENTS 2 0.0000
615 SKIN EXFOLIATION 1 0.0000
616 DEVICE ISSUE 1 0.0000
617 SUICIDAL IDEATION 1 0.0000
618 PULMONARY EMBOLISM 1 0.0000
619 NEUROPATHY PERIPHERAL 1 0.0000
620 DRUG INTOLERANCE 1 0.0000
621 SYNCOPE 1 0.0000
622 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
623 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
624 ABDOMINAL PAIN UPPER 2 0.0000
625 ABDOMINAL DISTENSION 1 0.0000
626 DEATH 7 0.0000
627 RENAL FAILURE 1 0.0000
628 PRODUCT QUALITY ISSUE 1 0.0000
629 HYPOAESTHESIA 1 0.0000
630 DRUG INTERACTION 1 0.0000
631 DRUG DEPENDENCE 1 0.0000
632 DRUG DOSE OMISSION 1 0.0000
633 NO ADVERSE EVENT 1 0.0000
634 ANAEMIA 1 0.0000
635 DEPRESSION 1 0.0000